Ropivacaine Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70069-062 -
Package NDC
70069-062-10 -
Package NDC
70069-062-25 -
Application number
ANDA207636 -
SPL ID
79b226f0-c08a-4f84-bf2b-ae5c60e01d67 -
SPL set ID
ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64 -
UNII
V910P86109 -
RxCUI
905189 -
RxCUI
1734084 -
RxCUI
1734090 -
RxCUI
1734203 -
RxCUI
1734207 -
RxCUI
1734475 -
RxCUI
1734483
What the source publishes
- Labeler
- Somerset Therapeutics, LLC
- Active ingredients
- Ropivacaine Hydrochloride
- Form
- INJECTION
- Routes
- EPIDURAL, INFILTRATION, PERINEURAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ropivacaine Hydrochloride",
"splId": "79b226f0-c08a-4f84-bf2b-ae5c60e01d67",
"labels": [
{
"setId": "ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"
}
],
"routes": [
"EPIDURAL",
"INFILTRATION",
"PERINEURAL"
],
"labeler": "Somerset Therapeutics, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 VIAL in 1 CARTON (70069-062-10) / 20 mL in 1 VIAL (70069-062-01)",
"package_ndc": "70069-062-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20220302"
},
{
"sample": false,
"description": "25 VIAL in 1 CARTON (70069-062-25) / 20 mL in 1 VIAL (70069-062-01)",
"package_ndc": "70069-062-25",
"identifierStatus": "well-formed",
"marketing_start_date": "20180615"
}
],
"productId": "70069-062_79b226f0-c08a-4f84-bf2b-ae5c60e01d67",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "70069-062",
"deaSchedule": null,
"genericName": "Ropivacaine Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ROPIVACAINE HYDROCHLORIDE",
"strength": "2 mg/mL"
}
],
"applicationNumber": "ANDA207636",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180615",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0370069062104",
"0370069062258",
"0370069064252",
"0370069061251",
"0370069064016",
"0370069063255",
"0370069067017",
"0370069066102",
"0370069067109",
"0370069063019",
"0370069061015",
"0370069065259",
"0370069062012",
"0370069064108",
"0370069066256",
"0370069067253",
"0370069061107",
"0370069066010",
"0370069065013"
],
"unii": [
"V910P86109"
],
"rxcui": [
"905189",
"1734084",
"1734090",
"1734203",
"1734207",
"1734475",
"1734483"
],
"spl_set_id": [
"ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"
],
"manufacturer_name": [
"Somerset Therapeutics, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70069-062_79b226f0-c08a-4f84-bf2b-ae5c60e01d67"